AI Analysis
Machine-generated analysis of the post above on 2026-10-20. Not written by the author of the post.
- One of six or more posts stamped within minutes, each ending in the identical typed signature 'President DONALD J. TRUMP'
- Sibling posts contain live-speech markers ('Here in Kansas', 'Tonight, I am also pleased to announce'), so the batch is a speech cut into posts
- Complete, grammatical sentence with no drift, self-interruption or typos
- Evening timing (8:18 PM Central / 9:18 PM Eastern) matches a live event, not late-night posting
- Trump's own diction is kept: capitalized nouns, ALL CAPS on HIGHEST/LOWEST, escalating number list
Strongest facet: Assertiveness expressed through achievement claims
Primary drive: achievement
Trigger: Supply Seeking (Midterm campaign speech to Kansas voters during a week of 33% approval polling)
Starting with Pfizer in late September 2025, the administration announced MFN pricing deals with several manufacturers (including AstraZeneca, EMD Serono, Eli Lilly and Novo Nordisk), covering Medicaid pricing, direct-to-consumer cash prices through TrumpRx, and pricing for new launches.
The first half is accurate: the US has long paid the highest brand-name drug prices among peer nations (RAND estimated US prices at about 2.8 times those of other OECD countries). The MFN deals cover selected drugs, the Medicaid channel and cash-pay sales. They don't apply across the commercial insurance market, and they peg prices to other wealthy countries rather than going below them. The deals are designed to bring US prices toward peer-country levels, so they can't make US prices the world's lowest. Many lower-income countries pay far less.
If read as price reductions, the figures are impossible: a price can't fall by more than 100%, and the reported discounts on covered drugs have generally been below that ceiling. If read as gaps between US and foreign prices, gaps of several hundred percent did exist for some brand drugs, but those measure how much more Americans paid, which contradicts the post's claim that the US now pays the least. This repeats the '400, 500, 600%' claim Trump has made since 2025, now extended to 700%.
No contradictions with other posts detected yet.
Monday night's Kansas rally for Senator Roger Marshall dominated the start of the day. Pieces of the speech went up on his account while he was still on stage, from a promised $5,000 "Trump Dividend" to a long passage describing France as being "burned to the ground" by migrants and claiming Democra...
A speech excerpt posted as one of a batch
This post is one of at least six Truth Social items stamped within minutes of each other on the evening of October 19 (01:18 UTC on the 20th is 8:18 PM Central, 9:18 PM Eastern). Each one ends with the same sign-off, "President DONALD J. TRUMP", and the batch reads like a campaign speech cut into paragraphs. The neighbouring posts give the setting away: "Here in Kansas, your Dumocrat Governor, Laura Kelly", "Tonight, I am also pleased to announce", "VOTE FOR TY MASTERSON FOR GOVERNOR". The events list doesn't settle whether he spoke in person or dialled in, as he did for the October 15 Iowa tele-rally, but either way the text is prepared remarks addressed to a Kansas audience in the last two weeks before the November 3 midterms.
That points to staff posting, with Trump's voice supplied by the script. The diction is his: the Capitalized Nouns ("Drug Prices", "Price Differences"), the shouted "HIGHEST" and "LOWEST", the climbing list of numbers. The structure isn't. The sentence is complete and grammatical, it doesn't drift or interrupt itself, and it ends on a typed signature, which Trump doesn't add to the posts he writes himself. The evening time fits a live speech being transcribed as he talks. It is not late-night posting.
Highest to lowest in one sentence
The whole post is a before-and-after: "we went from paying the HIGHEST Drug Prices anywhere in the World, to paying the LOWEST." The two ends are absolutes, and the post skips any account of how the change happened. This is the redemption pattern that runs through the whole batch ("We inherited the Worst Border... we turned it into the Strongest"). A bad inheritance is turned into a record achievement by one actor, named in the possessive at the start: "Under my Most Favored Nation Agreements." Credit goes to "my", and the benefit is shared with "we", a habit that recurs in his achievement claims. The audience gets the outcome and the speaker keeps ownership of it.
The dynamics are routine. The post seeks supply and maintains the base in a hard political week, with the October 18 Washington Post-ABC-Ipsos poll at 33% approval and the midterms two weeks out. It names no opponent, so there is no injury being answered and no anger. The state is grandiose throughout. The main defence is distortion: an international price ranking in which the US is still first is restated as its opposite. The binary "highest... lowest" has the shape of splitting, applied to a policy result rather than to people.
Percentages that can't work as percentages
The fact problem sits in the closing list: "Price Differences of 300, 400, 500, 600, or even 700%!" Since 2025 Trump has described drug-price cuts of "400, 500, 600%", and a price can't fall by more than 100%. This version swaps "reductions" for "differences" and adds 700. Read as a difference between US and foreign prices, gaps that size did exist for some brand drugs. But those gaps described Americans paying more, which contradicts the sentence's own claim that the US now pays the least. The new wording may be a scriptwriter's attempt to make the number defensible. If so, it saves the arithmetic only by reversing the claim.
"or even 700%" is the climax of an ascending list, a crescendo where the numbers do emotional work rather than measure anything. Because the list runs inside a scripted batch, the repetition and the escalating figure are better read as a rehearsed talking point than as perseveration. The text gives nothing to assess for cognitive change, since a staffer probably typed it from a speech.
Archetype and hierarchy
The post casts Trump as the Hero who comes back and repairs a broken system, with a vague cast of foreign countries and drugmakers implied as the old beneficiaries. It promises to restore order: Americans move from the top of the price table to the bottom, which the post presents as a fall in status for the rest of the world. Nobody is named or degraded. The distortion matters because it is about voters' own prescription costs, something they can check at the pharmacy counter.
Fact Verification
| Claim | Verdict | Evidence |
|---|---|---|
| "The administration reached Most Favored Nation agreements on drug prices" | True | Starting with Pfizer in late September 2025, the administration announced MFN pricing deals with several manufacturers (including AstraZeneca, EMD Serono, Eli Lilly and Novo Nordisk), covering Medicaid pricing, direct-to-consumer cash prices through TrumpRx, and pricing for new launches. |
| "The US went from paying the highest drug prices in the world to paying the lowest" | False | The first half is accurate: the US has long paid the highest brand-name drug prices among peer nations (RAND estimated US prices at about 2.8 times those of other OECD countries). The MFN deals cover selected drugs, the Medicaid channel and cash-pay sales. They don't apply across the commercial insurance market, and they peg prices to other wealthy countries rather than going below them. The deals are designed to bring US prices toward peer-country levels, so they can't make US prices the world's lowest. Many lower-income countries pay far less. |
| "The agreements produced price differences of 300, 400, 500, 600, or even 700%" | False | If read as price reductions, the figures are impossible: a price can't fall by more than 100%, and the reported discounts on covered drugs have generally been below that ceiling. If read as gaps between US and foreign prices, gaps of several hundred percent did exist for some brand drugs, but those measure how much more Americans paid, which contradicts the post's claim that the US now pays the least. This repeats the '400, 500, 600%' claim Trump has made since 2025, now extended to 700%. |
Overall Veracity: 33%
Post from Truth Social
Under my Most Favored Nation Agreements on Drug Prices, we went from paying the HIGHEST Drug Prices anywhere in the World, to paying the LOWEST Drug Prices, with Price Differences of 300, 400, 500, 600, or even 700%! President DONALD J. TRUMP